{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:27:04Z","timestamp":1775064424506,"version":"3.50.1"},"reference-count":105,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2017,4,19]],"date-time":"2017-04-19T00:00:00Z","timestamp":1492560000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK094600"],"award-info":[{"award-number":["DK094600"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005825","name":"National Institute of Food and Agriculture","doi-asserted-by":"publisher","award":["2009-65200-05846"],"award-info":[{"award-number":["2009-65200-05846"]}],"id":[{"id":"10.13039\/100005825","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0173376","type":"journal-article","created":{"date-parts":[[2017,4,19]],"date-time":"2017-04-19T13:30:38Z","timestamp":1492608638000},"page":"e0173376","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":53,"title":["Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-\/- mice"],"prefix":"10.1371","volume":"12","author":[{"given":"Kelli A.","family":"Lytle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen P.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9473-6283","authenticated-orcid":true,"given":"Donald B.","family":"Jump","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,4,19]]},"reference":[{"key":"ref1"},{"key":"ref2"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1002\/hep.20973","article-title":"Nonalcoholic fatty liver disease: from steatosis to cirrhosis","volume":"43","author":"GC Farrell","year":"2006","journal-title":"Hepatology"},{"issue":"6037","key":"ref4","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1126\/science.1204265","article-title":"Human fatty liver disease: old questions and new insights","volume":"332","author":"JC Cohen","year":"2011","journal-title":"Science"},{"issue":"1","key":"ref5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1159\/000282080","article-title":"Epidemiology of non-alcoholic fatty liver disease","volume":"28","author":"S Bellentani","year":"2010","journal-title":"Dig Dis"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"S186","DOI":"10.1046\/j.1440-1746.17.s1.10.x","article-title":"Non-alcoholic fatty liver disease","volume":"17","author":"P Angulo","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"ref7","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1053\/jhep.2003.50193","article-title":"Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference","volume":"37","author":"BA Neuschwander-Tetri","year":"2003","journal-title":"Hepatology"},{"issue":"6","key":"ref8","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/ajg.2012.128","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"107","author":"N Chalasani","year":"2012","journal-title":"The American journal of gastroenterology"},{"issue":"9491","key":"ref9","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome\u2014a new worldwide definition","volume":"366","author":"KG Alberti","year":"2005","journal-title":"Lancet"},{"issue":"3","key":"ref10","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"G Vernon","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 1","key":"ref11","first-page":"S17","article-title":"Pathophysiology of nonalcoholic steatohepatitis","volume":"40","author":"AJ McCullough","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"ref12","first-page":"205","article-title":"Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus","volume":"57","author":"M Prashanth","year":"2009","journal-title":"J Assoc Physicians India"},{"issue":"2","key":"ref13","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/hep.23314","article-title":"Decreased survival of subjects with elevated liver function tests during a 28-year follow-up","volume":"51","author":"C Soderberg","year":"2010","journal-title":"Hepatology"},{"issue":"4","key":"ref14","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Long-term follow-up of patients with NAFLD and elevated liver enzymes","volume":"44","author":"M Ekstedt","year":"2006","journal-title":"Hepatology"},{"issue":"1","key":"ref15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"The natural history of nonalcoholic fatty liver disease: a population-based cohort study","volume":"129","author":"LA Adams","year":"2005","journal-title":"Gastroenterology"},{"issue":"3","key":"ref16","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cld.2004.04.004","article-title":"The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease","volume":"8","author":"AJ McCullough","year":"2004","journal-title":"Clin Liver Dis"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1751-2980.2010.00469.x","article-title":"Epidemiology of the metabolic syndrome in the USA","volume":"12","author":"AJ McCollough","year":"2011","journal-title":"J Dig Dis"},{"issue":"6243","key":"ref18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1126\/science.349.6243.18","article-title":"The liver's weight problem","author":"M Leslie","year":"2015","journal-title":"Science"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"E Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"issue":"6","key":"ref20","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/j.1440-1746.2007.04977.x","article-title":"How should we manage patients with non-alcoholic fatty liver disease in 2007?","volume":"22","author":"HL Chan","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"issue":"7","key":"ref21","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology","volume":"142","author":"N Chalasani","year":"2012","journal-title":"Gastroenterology"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1136\/gutjnl-2014-306842","article-title":"Pathology of liver fibrosis: a translational success story","volume":"64","author":"YA Lee","year":"2015","journal-title":"Gut"},{"key":"ref23","article-title":"From crawl to sprint: the race to treat NASH","author":"R Kappler","year":"2015","journal-title":"Life Sci VC"},{"issue":"4","key":"ref24","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s00125-011-2446-4","article-title":"Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials","volume":"55","author":"G Musso","year":"2012","journal-title":"Diabetologia"},{"issue":"4","key":"ref25","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.clnu.2011.12.007","article-title":"Increased erythrocytes n-3 and n-6 polyunsaturated fatty acids is significantly associated with a lower prevalence of steatosis in patients with type 2 diabetes","volume":"31","author":"JM Petit","year":"2012","journal-title":"Clin Nutr"},{"issue":"6","key":"ref26","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s11745-012-3671-4","article-title":"Low docosahexaenoic acid content in plasma phospholipids is associated with increased non-alcoholic fatty liver disease in China","volume":"47","author":"JS Zheng","year":"2012","journal-title":"Lipids"},{"issue":"4","key":"ref27","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.jhep.2011.08.018","article-title":"Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"56","author":"HM Parker","year":"2012","journal-title":"J Hepatol"},{"issue":"41","key":"ref28","doi-asserted-by":"publisher","first-page":"5839","DOI":"10.3748\/wjg.v18.i41.5839","article-title":"Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease","volume":"18","author":"MN Di Minno","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"4","key":"ref29","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1136\/adc.2010.192401","article-title":"Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial","volume":"96","author":"V Nobili","year":"2011","journal-title":"Arch Dis Child"},{"issue":"1","key":"ref30","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.clnu.2010.06.001","article-title":"The therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver disease","volume":"30","author":"H Shapiro","year":"2011","journal-title":"Clin Nutr"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1007\/s10620-014-3380-3","article-title":"Total body weight loss of \u226510% is associated with improved hepatic fibrosis in patients with nonalcoholic steatohepatitis","volume":"60","author":"LM Glass","year":"2015","journal-title":"Dig Dis Sci"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"7339","DOI":"10.3748\/wjg.v20.i23.7339","article-title":"Mediterranean diet and non-alcoholic fatty liver disease","volume":"20","author":"F Sofi","year":"2014","journal-title":"World journal of gastroenterology: WJG"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jhep.2014.10.023","article-title":"NAFLD incidence and remission: Only a matter of weight gain and weight loss?","volume":"62","author":"G Marchesini","year":"2015","journal-title":"J Hepatology"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.jand.2014.01.009","article-title":"A cross-sectional study assessing dietary intake and physical activity in Canadian patients with nonalcoholic fatty liver disease vs health controls","volume":"114","author":"HE Da Silva","year":"2014","journal-title":"J Acad Nutr Diet"},{"key":"ref35","first-page":"1","article-title":"Potential for dietary omega-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer","volume":"6","author":"DB Jump","year":"2015","journal-title":"Adv Nutr"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1194\/jlr.M050062","article-title":"Fatty acid elongase-5 (Elovl5) regulates hepatic triglyceride catabolism in obese C57BL\/6J mice","volume":"55","author":"S Tripathy","year":"2014","journal-title":"J Lipid Res"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1146\/annurev-nutr-071812-161139","article-title":"Fatty Acid-regulated transcription factors in the liver","volume":"33","author":"DB Jump","year":"2013","journal-title":"Annu Rev Nutr"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S002966511500244X","article-title":"Impact of dietary fat on the development of non-alcoholic fatty liver disease in Ldlr-\/- mice","volume":"75","author":"DB Jump","year":"2016","journal-title":"Proc Nutrition Soc"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"592S","DOI":"10.3945\/jn.111.155259","article-title":"Mechanisms of action of (n-3) fatty acids","volume":"142","author":"PC Calder","year":"2012","journal-title":"J Nutr"},{"issue":"3","key":"ref40","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3945\/jn.112.171322","article-title":"Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-\/-) mouse model of western diet-induced nonalcoholic steatohepatitis","volume":"143","author":"CM Depner","year":"2013","journal-title":"J Nutr"},{"issue":"12","key":"ref41","doi-asserted-by":"publisher","first-page":"e83756","DOI":"10.1371\/journal.pone.0083756","article-title":"A metabolomic analysis of omega-3 fatty acid mediated attenuation of western diet-induced non-alcoholic steatohepatitis in LDLR-\/- mice","volume":"8","author":"CM Depner","year":"2013","journal-title":"Plos One"},{"issue":"5","key":"ref42","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1002\/hep.27695","article-title":"Altered hepatic gene expression in non-alcoholic fatty liver disease is associated with lower n-3 and n-6 polyunsaturated fatty acids","volume":"61","author":"BM Arendt","year":"2015","journal-title":"Hepatology"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jhep.2007.09.009","article-title":"Nutrition assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study","volume":"48","author":"JB Allard","year":"2007","journal-title":"J Hepatol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3945\/jn.108.101782","article-title":"Hepatic fatty acid composition differs between chronic hepatitis C patients with and without steatosis","volume":"139","author":"BM Arendt","year":"2009","journal-title":"The Journal of nutrition"},{"issue":"10","key":"ref45","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1194\/jlr.M900022-JLR200","article-title":"Dietary sucrose is essential to the development of liver injury in the methionine-choline-deficient model of steatohepatitis","volume":"50","author":"MK Pickens","year":"2009","journal-title":"J Lipid Res"},{"issue":"5","key":"ref46","doi-asserted-by":"crossref","first-page":"R1319","DOI":"10.1152\/ajpregu.1996.271.5.R1319","article-title":"Changes in insulin action, triglycerides, and lipid composition during sucrose feeding in rats","volume":"271","author":"MJ Pagliassotti","year":"1996","journal-title":"American Journal of Physiology-Regulatory, Integrative and Comparative Physiology"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/ajcn.81.2.341","article-title":"Orgins and evolution of the western diet: health implications for the 21st century","volume":"81","author":"L Cordain","year":"2005","journal-title":"Am J Clin Nutr"},{"issue":"7","key":"ref48","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.4254\/wjh.v7.i30.2962","article-title":"Management of non-alcoholic fatty liver disease in 2015","volume":"26","author":"N Malhotra","year":"2015","journal-title":"World J Hepatol"},{"issue":"7","key":"ref49","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.4254\/wjh.v7.i24.2522","article-title":"Dietary approach in the treatment of nonalcoholic fatty liver disease","volume":"28","author":"SM Ferolla","year":"2015","journal-title":"World J Hepatol"},{"issue":"1","key":"ref50","doi-asserted-by":"publisher","first-page":"e0146942","DOI":"10.1371\/journal.pone.0146942","article-title":"Is western diet-induced nonalcoholic steatohepatitis in Ldlr-\/- mice reversible?","volume":"11","author":"KA Lytle","year":"2016","journal-title":"PLoS One"},{"issue":"8","key":"ref51","doi-asserted-by":"publisher","first-page":"792","DOI":"10.3109\/09637486.2010.487480","article-title":"Effects of a 1-year dietary intervention with n-3 polyunsaturated fatty acid-enriched olive oil on non-alcoholic fatty liver disease patients: a preliminary study","volume":"61","author":"F Sofi","year":"2011","journal-title":"Int J Food Sci Nutr"},{"issue":"10","key":"ref52","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1097\/MEG.0b013e32833b257a","article-title":"Treatment with omega-3 fatty acids but not exendin-4 improves hepatic steatosis","volume":"22","author":"DG Bulchandani","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"7","key":"ref53","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1253\/circj.CJ-09-0520","article-title":"Preventive effects of eicosapentaenoic acid on coronary artery disease in patients with peripheral artery disease","volume":"74","author":"Y Ishikawa","year":"2011","journal-title":"Circ J"},{"issue":"1","key":"ref54","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1515\/CCLM.2011.020","article-title":"Low concentrations of serum n-3 polyunsaturated fatty acids in non-alcoholic fatty liver disease patients with liver injury","volume":"49","author":"T Kishino","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1002\/hep.27289","article-title":"Effects of purified eicosapentaenoic and docosahexaenoic acids in non-alcoholic fatty liver disease: Results from the *WELCOME study","volume":"60","author":"E Scorletti","year":"2014","journal-title":"Hepatology"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jhep.2014.08.036","article-title":"Effects of n-3 fish oil on metabolic and histological parameters in NASH: a double-blind, randomized, placebo-controlled trial","volume":"62","author":"CK Argo","year":"2015","journal-title":"J Hepatology"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1053\/j.gastro.2014.04.046","article-title":"No significant effects of ethyl-eicosapentaenoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial","volume":"147","author":"AJ Sanyal","year":"2014","journal-title":"Gastroenterology"},{"issue":"2","key":"ref58","doi-asserted-by":"publisher","first-page":"99","DOI":"10.5551\/jat.5876","article-title":"Relationships between plasma fatty acid composition and coronary artery disease","volume":"18","author":"H Itakura","year":"2011","journal-title":"J Atheroscler Thromb"},{"issue":"8","key":"ref59","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.3945\/jn.112.158865","article-title":"Menhaden oil decreases high-fat diet-induced markers of hepatic damage, steatosis, inflammation, and fibrosis in obese Ldlr-\/- mice","volume":"142","author":"CM Depner","year":"2012","journal-title":"J Nutr"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1194\/jlr.M061275","article-title":"Docosahexaenoic acid attenuates western diet induced hepatic fibrosis in Ldlr-\/- mice by targeting the TGF-beta-Smad pathway","volume":"56","author":"KA Lytle","year":"2015","journal-title":"J Lipid Res"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1172\/JCI66028","article-title":"Evolving therapies for liver fibrosis","volume":"123","author":"D Schuppan","year":"2013","journal-title":"J Clin Invest"},{"issue":"5","key":"ref62","doi-asserted-by":"publisher","first-page":"e0127991","DOI":"10.1371\/journal.pone.0127991","article-title":"Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease","volume":"10","author":"MV Machado","year":"2015","journal-title":"PloS One"},{"issue":"8","key":"ref63","doi-asserted-by":"publisher","first-page":"5288","DOI":"10.4049\/jimmunol.178.8.5288","article-title":"Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis","volume":"178","author":"JA Fallowfield","year":"2007","journal-title":"The Journal of Immunology"},{"issue":"3","key":"ref64","doi-asserted-by":"publisher","first-page":"G323","DOI":"10.1152\/ajpgi.00394.2009","article-title":"Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis","volume":"298","author":"Y Popov","year":"2010","journal-title":"American Journal of Physiology-Gastrointestinal and Liver Physiology"},{"issue":"1","key":"ref65","doi-asserted-by":"publisher","first-page":"e30668","DOI":"10.1371\/journal.pone.0030668","article-title":"LDL receptor knock-out mice are a physiological model particularly vulnerable to study the onset of inflammation in non-alcoholic fatty liver disease","volume":"7","author":"V Bieghs","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"ref66","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.3945\/jn.112.158865","article-title":"Menhaden Oil Decreases High-Fat Diet\u2013Induced Markers of Hepatic Damage, Steatosis, Inflammation, and Fibrosis in Obese Ldlr\u2212\/\u2212 Mice","volume":"142","author":"CM Depner","year":"2012","journal-title":"The Journal of nutrition"},{"issue":"3","key":"ref67","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3945\/jn.112.171322","article-title":"Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr\u2212\/\u2212 mouse model of western diet-induced nonalcoholic steatohepatitis","volume":"143","author":"CM Depner","year":"2013","journal-title":"The Journal of nutrition"},{"issue":"8","key":"ref68","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.amjcard.2008.05.056","article-title":"Effectiveness of combined statin plus omega-3 fatty acid therapy for mixed dyslipidemia","volume":"102","author":"P Barter","year":"2008","journal-title":"Am J Cardiol"},{"issue":"2","key":"ref69","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2009.05.024","article-title":"Efficacy and safety of prescription omega-3-acid ethyl esters for the prevention of recurrent symptomatic atrial fibrillation: a prospective study","volume":"158","author":"CM Pratt","year":"2009","journal-title":"Am Heart J"},{"issue":"9","key":"ref70","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1194\/jlr.M006080","article-title":"Elevated hepatic fatty acid elongase-5 activity corrects dietary fat-induced hyperglycemia in obese BL\/6J mice","volume":"51","author":"S Tripathy","year":"2010","journal-title":"J Lipid Res"},{"issue":"5","key":"ref71","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.bcp.2010.12.014","article-title":"Soraphen A, an inhibitor of acetyl CoA carboxylase activity, interferes with fatty acid elongation","volume":"81","author":"DB Jump","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"ref72","first-page":"gkv380","article-title":"MetaboAnalyst 3.0\u2014making metabolomics more meaningful","author":"J Xia","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/hepr.12166","article-title":"Osteopontin: Versatile modulator of liver diseases","volume":"44","author":"S Nagoshi","year":"2013","journal-title":"Hepatology Research"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.matbio.2015.01.004","article-title":"Matrix metalloproteases in liver injury, repair and fibrosis","volume":"44-66C","author":"S Duarte","year":"2015","journal-title":"Matrix Biology"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.tem.2015.01.002","article-title":"Adipocytokines and hepatic fibrosis","volume":"26","author":"NK Saxena","year":"2015","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"ref76","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1210\/jc.2013-3092","article-title":"Toll-like receptor status in obesity and metabolic syndrome: a translational perspective","volume":"99","author":"I Jialal","year":"2014","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"7381","DOI":"10.3748\/wjg.v20.i23.7381","article-title":"Role of gut microbiota and toll-like receptors in nonalcoholic fatty liver disease","volume":"20","author":"K Miura","year":"2014","journal-title":"World J Gastroentero"},{"issue":"Suppl 1","key":"ref78","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/jgh.12019","article-title":"Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis","volume":"28","author":"YS Roh","year":"2013","journal-title":"Journal of gastroenterology and hepatology"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1753-4887.2009.00259.x","article-title":"Modulation of pattern recognitiion receptor-mediated inflammation and risk of chronic diseases by dietary fatty acids","volume":"68","author":"J Lee","year":"2011","journal-title":"Nutr Rev"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1136\/gutjnl-2014-307712","article-title":"Osteopontin: a new player in regulating hepatic ductular reaction and hepatic progenitor cell responses during chronic liver injury","volume":"63","author":"M Strazzabosco","year":"2014","journal-title":"Gut"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1002\/hep.28289","article-title":"Inhibition of hedgehog signaling ameliorates hepatic inflammation in mice with nonalcoholic fatty liver disease","volume":"63","author":"H Kwon","year":"2016","journal-title":"Hepatology"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"40589","DOI":"10.1074\/jbc.M504166200","article-title":"The vitamin D receptor, Runx2, and the Notch signaling pathway cooperate in the transcriptional regulation of osteopontin","volume":"280","author":"Q Shen","year":"2005","journal-title":"J Biol Chem"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.3748\/wjg.v18.i26.3389","article-title":"Osteopontin increases hepatocellular carcinoma cell growth in a CD44-dependent manner","volume":"18","author":"RJ Phillps","year":"2012","journal-title":"World J Gastroentero"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"e24169","DOI":"10.4161\/onci.24169","article-title":"Osteopontin, a possible modulator of cancer stem cells and their malignant niche","volume":"25","author":"G Rao","year":"2013","journal-title":"Oncoimmunology"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nri1497","article-title":"Consequences of regulated pre-mRNA splicing in the immune system","volume":"4","author":"KW Lynch","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrm1004","article-title":"CD44: From adhesion molecules to signalling regulators","volume":"4","author":"H Ponta","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref87","article-title":"Circulating osteopontin and prediction of hepatocellular carcinoma development ina large eutopean population","author":"T Duarte-Salles","year":"2016","journal-title":"Cancer Prev Res"},{"key":"ref88","article-title":"Signalling via the osteopontin and high mobility group box-1 axis drives the fibrogenic response to liver injury","author":"E Arrizazu","year":"2016","journal-title":"Gut"},{"issue":"2","key":"ref89","first-page":"179","article-title":"Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells","volume":"124","author":"P Libby","year":"1986","journal-title":"The American journal of pathology"},{"issue":"22","key":"ref90","doi-asserted-by":"publisher","first-page":"R760","DOI":"10.1016\/S0960-9822(02)01286-1","article-title":"Interleukin signaling","volume":"12","author":"C Vosshenrich","year":"2002","journal-title":"Curr Biol"},{"issue":"4","key":"ref91","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/jlb.67.4.508","article-title":"The interleukin-1 receptor\/Toll-like receptor superfamily: signal generators for pro-inflammatory interleukins and microbial products","volume":"67","author":"A Bowie","year":"2000","journal-title":"J Leukocyte Biol"},{"issue":"2","key":"ref92","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/hep.22680","article-title":"The interleukin\u201017 pathway is involved in human alcoholic liver disease","volume":"49","author":"A Lemmers","year":"2009","journal-title":"Hepatology"},{"issue":"5","key":"ref93","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.bbamcr.2011.01.034","article-title":"The pro-and anti-inflammatory properties of the cytokine interleukin-6","volume":"1813","author":"J Scheller","year":"2011","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Cell Research"},{"issue":"6","key":"ref94","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1002\/hep.510280620","article-title":"Interleukin\u201010 expression and function in experimental murine liver inflammation and fibrosis","volume":"28","author":"K Thompson","year":"1998","journal-title":"Hepatology"},{"issue":"1","key":"ref95","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1034\/j.1600-0528.2002.017418.x","article-title":"Pathophysiological roles of interleukin\u201018 in inflammatory liver diseases","volume":"174","author":"H Tsutsui","year":"2000","journal-title":"Immunol Rev"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.bbalip.2014.08.010","article-title":"Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance","volume":"1851","author":"PC Calder","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"e0127518","DOI":"10.1371\/journal.pone.0127518","article-title":"Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma","volume":"10","author":"X Liu","year":"2015","journal-title":"PLoS One"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"5199","DOI":"10.3390\/ijms15045199","article-title":"Potential role of bone morphogenetic protein (Bmp)-9 in human liver diseases","volume":"15","author":"B Herrera","year":"2014","journal-title":"Int J Mol Sci"},{"issue":"303","key":"ref99","article-title":"Hepatoprotective and anti-fibrotic agents: It's time to take the next step","volume":"6","author":"R Weiskirchen","year":"2016","journal-title":"Frontiers in Pharmacology"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.matbio.2015.01.004","article-title":"Matrix metalloproteinases in liver injury, repair and fibrosis","volume":"44","author":"S Duarte","year":"2015","journal-title":"Matrix Biol"},{"issue":"9","key":"ref101","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1194\/jlr.M006080","article-title":"Elevated hepatic fatty acid elongase-5 activity corrects dietary fat-induced hyperglycemia in obese C57BL\/6J mice","volume":"51","author":"S Tripathy","year":"2010","journal-title":"J Lipid Res"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1194\/jlr.M028787","article-title":"Elovl5 Regulates the mTORC2-Akt-FOXO1 Pathway by Controlling Hepatic cis-Vaccenic Acid Synthesis in Diet-Induced Obese Mice","volume":"54","author":"S Tripathy","year":"2013","journal-title":"J Lipid Res"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S1388-1981(00)00077-9","article-title":"Metabolism of highly unsaturated n-3 and n-6 fatty acids","volume":"1486","author":"H Sprecher","year":"2000","journal-title":"Biochimica et Biophysica Acta"},{"key":"ref104","first-page":"1","article-title":"Role of FGFs as paracrine and endocrine signals in liver development, health and disease","volume":"4","author":"N Itoh","year":"2016","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"ref105","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/ng1961","article-title":"Fgf10 regulates hepatopancreatic ductal system patterning and differentiation","volume":"39","author":"PDS Dong","year":"2007","journal-title":"Nat Genet"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0173376","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T05:12:04Z","timestamp":1569042724000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0173376"}},"subtitle":[],"editor":[{"given":"Anna","family":"Alisi","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,4,19]]},"references-count":105,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,4,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0173376","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,19]]}}}